Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

Conditions:   Pancreatic Cancer;   Pancreatic Neoplasms;   Pancreatic Ductal Adenocarcinoma;   Advanced Cancer Interventions:   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Mutant KRAS G12V-specific TCR tranduced autologous T cells;   Drug: Anti-PD-1 monoclonal antibody Sponsors:   Guo ShiWei;   Providence Cancer Center, Earle A. Chiles Research Institute Not yet recruiting

Source: ClinicalTrials.gov - October 31, 2019 Category: Research Source Type: clinical trials